Home Clinical Trial Updates

Clinical Trial Updates

Latest

Acalabrutinib Significantly Improves Progression-Free Survival in Chronic Lymphocytic Leukemia

Peter Hofland, Ph.D -
Blood

First Patient Enrolled in Non-Pharmaceutical Multi-Center, Triple-Negative Breast Cancer Clinical Trial

Peter Hofland, Ph.D -
General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019 ? ASCO/Luke Franke 2019.

RC48-ADC Shows Clinically Meaningful Results in Advanced HER2+ Urothelial Cancer

Peter Hofland, Ph.D -
General view of the 55th Annual Meeting of the American Society of Oncology (ASCO). Courtesey: 2019 ? ASCO/Kristen Norman 2019.

Changing Clinical Trial Enrollment Criteria Dramatically Increases Participation of Eligible Patients...

Peter Hofland, Ph.D -
Surgeons using surgical instruments for keyhole surgery, watching the monitor which displays images from inside the patient's abdomen - operating theater with lights in the background.

Laparoscopic Surgery vs. Open Surgery in Patients with Colorectal Cancer with...

Peter Hofland, Ph.D -

Results of Liso-Cel in Patients with Difficult-to-Treat Blood Cancers Presented at...

Peter Hofland, Ph.D -
Exhibition booth Seattle Genetics - ASCO 2019 | Courtsey: Emila Duaerte / Sunvalley Communication

Enfortumab Vedotin Produces a High Tumor Response Rate in Patients with...

Peter Hofland, Ph.D -
Attendees networking during during the American Society of Clinical Oncology (ASCO) Annual Meeting. Courtesy: ? ASCO/Danny Morton

Sub-population Analysis Shows High Rates of Durable Response and Overall Survival...

Peter Hofland, Ph.D -
Cg render of t-cells

Phase I ZUMA-3 Results for KTE-X19 in ALL Show High Rates...

Peter Hofland, Ph.D -
Netherlands Cancer Institute in Amsterdam, The Netherlands

Prioritizing the Importance of the Immune System

Danielle Garcia -
123...16Page 1 of 16

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.